Posts Tagged 'Daiichi Sankyo'

Daiichi-Sankyo Announces Benicar Settlement in Strongly Worded Press Release

daiichi-sankyo announces benicar settlement“The impact to the financial position of the company is not considered material because, upon presentation of proper claim documentation, the settlement fund is expected to be comprised primarily of proceeds from several of Daiichi Sankyo Group’s insurance companies supplemented with company funds.

Daiichi Sankyo believes that the claims made in this litigation are without merit, and does not admit liability.”

We don’t believe we did anything wrong and it doesn’t matter much anyway because ...

continue reading...

New Study: Benicar Side Effects Resemble Celiac Disease Symptoms

benicar side effects resemble celiac symptomsA new study in the journal Alimentary Pharmacology and Therapeutics has found that intestinal side effects caused by using Benicar (olmesartan) are similar to the symptoms of celiac disease.

Benicar is Japan-based company Daiichi Sankyo’s bestselling hypertension drug. The U.S. Food and Drug Administration (FDA) approved Benicar in 2002, and since then the drug has been prescribed to over 11 million U.S. patients. But in 2013, the agency ...

continue reading...

As Benicar Lawsuits Top 1,000, Plaintiffs Ask: What Took So Long?

victims wonder why FDA action on Benicar took so longBenicar lawsuits consolidated in the New Jersey multidistrict litigation now exceed 1,000, and as more pour in, Benicar plaintiffs continue to ask: What took the U.S. Food and Drug Administration (FDA) so long to warn patients about the drug’s severe gastrointestinal side effects?

Daiichi Sankyo’s Benicar was approved by the FDA in 2002 to help treat patients with high blood pressure. It quickly became one of the ...

continue reading...

Benicar Lawsuits Consolidated

benicar lawsuits consolidated into multidistrict litigationThe U.S. Judicial Panel on Multidistrict Litigation has ruled to consolidate lawsuits alleging that Benicar, Daiichi Sankyo’s brand-name olmesartan, can cause serious gastrointestinal issues. According to Reuters, the panel handed down its ruling after a March 26 hearing in the U.S. District Court for the Southern District of California.

Benicar was approved by the U.S. Food and Drug Administration (FDA) in 2002 for use as a blood pressure medication. Since ...

continue reading...

Benicar Maker Daiichi Sankyo to Lay Off 16% of US Staff

benicar maker to lay off employeesPharmaceutical giant Daiichi Sankyo, maker of the blood pressure drug Benicar, will begin laying off 16 percent of its U.S. staff at its headquarters in Parsippany, NJ. The company has also announced plans to cut even more staff starting in mid-April.

Sankyo’s most recent nine-month report indicates that the company’s North American revenue increased 6 percent from the previous year but fell by 1.5 percent in terms of local ...

continue reading...

PA to Receive $90,000 of $39 Million Daiichi Sankyo Settlement

benicar maker settles case for 39 million dollarsPennsylvania will receive $90,000 of the $39 million that Daiichi Sankyo must pay in damages and penalties to 49 U.S. states, Washington, DC, and the federal government. The National Association of Medicaid Fraud Control and the federal government recently reached the settlement with Daiichi Sankyo after the New Jersey–based pharmaceutical giant was found to have violated federal law in promoting their drugs Azor, Welchol, Tribenzor, and Benicar.

A former ...

continue reading...
Page 1 of 2 12